key topics
navigation
|
Nonsteroidal Antiinflammatory Drugs
NSAIDs are a group of medications often used to treat a variety of mild to moderate arthritis pain and inflammation. While these medications have long been considered a therapeutic mainstay in the treatment of arthropathies including osteoarthritis, the Food and Drug Administration did request labeling changes to all non-selective NSAIDs in 2005.
Point/Counterpoint: Cox II Inhibitors: Do The Pros Outweigh The Cons?
Yes, Jim Meeks, PA-C, says Cox-II inhibitors can be effective with appropriate patient selection. No, Blaine P. Carmichael, MPAS, PA-C, notes that various studies have shown elevated risks of cardiovascular and renal side effects with these drugs.
NSAIDs: Where Do We Go From Here?
Given the heightened awareness over potential side effects of nonsteroidal antiinflammatory drugs, this author discusses key considerations in prescribing these medications.
A Closer Look At The EULAR Guidelines For OA In The Hand
Our roundtable panelists offer their take on the recent EULAR guidelines for managing osteoarthritis (OA) in the hand and provide pertinent pearls from their clinical experience in treating OA hand pain.
A Closer Look At Combination Therapy For RA
Given the debilitating effects of rheumatoid arthritis and recent changes in the evolution of RA treatment, these authors review the literature and discuss the potential impact of combination therapy for this disease.
Case Studies In Diagnosing And Treating Gout
Given the challenges of diagnosing gout, this author provides four case studies that convey pertinent keys to the diagnostic workup and evaluation of this patient population, and offers salient insights on treatment as well.
Point/Counterpoint: Should You Prescribe Steroids For Rheumatoid Arthritis?
Yes, Dr. Deane says many studies have pointed to the positive results of treating rheumatoid arthritis (RA) with glucocorticoids. No, Dr. Goldman says corticosteroids have a significantly reduced role in the treatment of RA.
When A Cross-Country Runner Has Knee Swelling
s syndrome) B. Juvenile chronic arthritis (juvenile rheumatoid arthritis) C. Lyme disease D. Osgood? With pauci- or oligoarticular juvenile arthritis, which occurs in 50 percent of cases of juvenile arthritis, systemic symptoms are minimal. About 10 percent of patients with arthritis may experience prolonged (over one year) episodes of arthritis.
How To Detect And Treat Septic Bursitis
Given the challenges of diagnosing septic bursitis, these authors discuss key clinical signs, pertinent diagnostic tests and insights on effective treatment.
Essential Keys To Detecting Early RA
Early detection of rheumatoid arthritis can go a long way toward reducing the risks of joint damage and disability. Accordingly, these authors offer pertinent diagnostic insights to look for in the clinical exam, patient history, lab tests and imaging modalities.
What Does The Future Hold For Etoricoxib?
Two studies published separately in The Lancet in recent months discussed results from the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study, which involved 34,701 patients with OA or RA. Combination Therapy For Early RA: What One Study Reveals By Aaron Becker, Associate Editor When it comes to early rheumatoid arthritis (RA), initial combination therapy provides ? While the study suggests that cognitive behavioral therapy can be effective for patients with depression...
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
|